New Trial Tests Mixing
2 Different COVID-19 Vaccines .
The clinical trial launched in
the United Kingdom on Thursday.
As part of the study, patients will receive one
dose of the AstraZeneca vaccine, followed by
a dose of the Pfizer vaccine or vice versa.
The U.K.’s Department of Health said the trial is the
first of its kind and will test the safety of mixing
vaccines for first and second doses.
The study, named “Com-Cov,” will
span over 13 months and provide
its initial findings by summer.
This is a hugely important clinical trial that will provide us with more vital evidence on the safety of these vaccines when used in different ways, Minister for Covid-19 vaccine deployment
Nadhim Zahawi, via statement.
The Centers for Disease Control and Prevention in the U.S. recently changed its guidance to say the Moderna and Pfizer vaccines could be mixed in "exceptional situations."